IM Cannabis Corp. Welcomes Shmulik Arbel to Its Board of Directors
IM Cannabis Corp. (NASDAQ: IMCC) is excited to announce that Shmulik Arbel has joined its Board of Directors. This appointment represents a strategic move for the company as it aims to enhance its governance and strategic growth initiatives.
Experience of Shmulik Arbel in Banking and Finance
Arbel brings a substantial wealth of experience from his previous role at Leumi, one of the largest banking institutions, where he served as Deputy CEO until recently. His diverse background in banking and finance will support IM Cannabis' commitment to sustainable, profitable growth in the competitive cannabis market.
Comments from Leadership
Oren Shuster, CEO of IM Cannabis, expressed his enthusiasm about Arbel's appointment, stating, "We are thrilled to welcome Shmulik to our Board of Directors. His extensive international experience and proven track record will be invaluable as we continue to deliver our strategic initiatives." Arbel’s banking expertise is expected to play a crucial role in enhancing the company’s performance.
Arbel's Vision for IM Cannabis
Upon joining the board, Arbel remarked, "I am honored to be part of IM Cannabis. I look forward to leveraging my expertise in banking and finance to further enhance the company's position in the global cannabis market and contribute to its growth trajectory." His insights are anticipated to provide valuable guidance as the company expands its presence worldwide.
About IM Cannabis Corp.
IM Cannabis Corp. positions itself as a leading player in the international medical cannabis space, providing high-quality products to patients in various markets. Focusing heavily on Israel and Germany, IM Cannabis aims to achieve sustainable growth leveraging a unique data-driven approach. The company operates through a robust ecosystem involving distribution centers and retail pharmacies, ensuring quality and safety in its supply chain.
In Germany, IM Cannabis collaborates with Adjupharm GmbH, expanding its ability to distribute medical cannabis effectively. This strategic alignment is designed to enhance the accessibility of premium cannabis products while maintaining the highest standards of compliance.
Growth and Strategy
With the recent appointment of Shmulik Arbel, IM Cannabis is poised to continue its focus on establishing a strong presence in major markets. The company’s strategy emphasizes responsible growth, commitment to compliance, and leveraging insights from accumulated data over the years. This proactive approach aims to enhance IM Cannabis' brand and operational efficiency, making it a distinguished player in the cannabis industry.
Company Contact
For additional information, please reach out to the following contacts:
Anna Taranko
Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
a.taranko@imcannabis.de
Oren Shuster
CEO
IM Cannabis Corp.
info@imcannabis.com
Frequently Asked Questions
What is IM Cannabis Corp.?
IM Cannabis Corp. is a leading international company in the medical cannabis sector, focusing on providing premium cannabis products.
Who is Shmulik Arbel?
Shmulik Arbel is the newly appointed member of the Board of Directors at IM Cannabis, with extensive experience in banking and finance.
Why is Shmulik Arbel's appointment significant?
His experience is expected to strengthen the company's governance and drive profitable growth, especially in strategic markets.
What markets does IM Cannabis focus on?
The company primarily focuses on medical cannabis markets in Germany and Israel.
How can I contact IM Cannabis for more information?
You can contact Anna Taranko or Oren Shuster via the provided email addresses for investor inquiries.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.